Michael Hunkapiller

Michael Hunkapiller is a declared insider of Pacific Biosciences of California, Inc., with filings sourced from SEC (Form 4). In total, 126 filings cover trades dated from 9 August 2011 to 26 February 2021.

Both buying and selling appear: 20 purchases worth €2.9M, against 71 sales worth €117.2M. Taken together, the sales exceed the purchases by €114.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 30 option exercises. 2021 to date brings no purchases and 44 sales.

Half of the purchases are above €116k and half below. Ninety days after publication, 20 purchases show a median change of +41.4%, with the price up in 80% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 2 March 2021, the filings show an option exercise worth €516k in Pacific Biosciences of California, Inc. The clock since the last published purchase (12 December 2013) now reads 4,714 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.